N-Palmitoyl glycine activates transient receptor potential channel 5 and increases the risk of Brugada syndrome

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Chinese National Natural Science Foundation (Grant No. 81930105 and 82370312).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The UKB participants gave informed written consent, and ethical approval was obtained from the North West Centre for Research Ethics Committee. The deCode participants who donated samples gave informed consent, and the National Bioethics Committee of Iceland approved the study. The All GWAS human participants provided written informed consent, and all studies had received approval from the appropriate ethical review boards. The animal ethical clearance was granted by the Institutional Animal Care and Use Committee of Peking University First Hospital (approved number: J2024090), affirming the conscientiousness of their treatment and welfare.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes